Compounds > piperacillin
Page last updated: 2024-08-23

piperacillin and Body Weight

piperacillin has been researched along with Body Weight in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (20.00)18.2507
2000's1 (10.00)29.6817
2010's5 (50.00)24.3611
2020's2 (20.00)2.80

Authors

AuthorsStudies
Albertsen, BK; Friberg, LE; Maarbjerg, SF; Nielsen, EI; Schrøder, H; Thorsted, A; Wang, M1
Jang, SM; Lewis, SJ; Rhie, SJ1
Brock, B; Friberg, LE; Kristoffersson, AN; Maarbjerg, SF; Nielsen, EI; Schrøder, H; Thorsted, A; Wang, M1
Cheatham, SC; Chung, EK; Fleming, MR; Healy, DP; Kays, MB; Shea, KM1
Chen, R; Qian, CY; Qian, Q; Sun, MR; Wang, LY; Wang, ML; Zou, SL1
Calvo, G; Fernández, J; Llauradó-Serra, M; Martín-Loeches, I; Pontes, C; Rodríguez, A; Soy, D; Torres, A; Ulldemolins, M; Vaquer, S1
Cao, D; Cao, Y; Chen, C; Chen, Y; Li, Q; Li, Z; Shi, W; Wang, Y; Wu, D; Zhu, Y1
Alexander, JJ; Gobburu, JV; Imoisili, MA; Korth-Bradley, JM; Tornøe, CW; Tworzyanski, JJ1
Arimori, K; Kitagawa, A; Kobayashi, M; Nakamura, C; Nakano, M; Tokunaga, J1
Aguirre, C; Barreiro, G; Ruiz-Irastorza, G1

Trials

2 trial(s) available for piperacillin and Body Weight

ArticleYear
Population pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese and nonobese patients.
    Journal of clinical pharmacology, 2015, Volume: 55, Issue:8

    Topics: Adult; Aged; Anti-Bacterial Agents; Body Mass Index; Body Weight; Computer Simulation; Creatinine; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Models, Biological; Monte Carlo Method; Obesity; Penicillanic Acid; Piperacillin; Tazobactam

2015
Population pharmacokinetics of piperacillin/tazobactam in neonates and young infants.
    European journal of clinical pharmacology, 2013, Volume: 69, Issue:6

    Topics: Age Factors; Anti-Bacterial Agents; Body Weight; China; Computer Simulation; Drug Dosage Calculations; Drug Monitoring; Female; Humans; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Male; Models, Biological; Nonlinear Dynamics; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination

2013

Other Studies

8 other study(ies) available for piperacillin and Body Weight

ArticleYear
Continuous infusion of piperacillin-tazobactam significantly improves target attainment in children with cancer and fever.
    Cancer reports (Hoboken, N.J.), 2022, Volume: 5, Issue:10

    Topics: Anti-Bacterial Agents; Body Weight; Child; Febrile Neutropenia; Fever; Humans; Neoplasms; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies

2022
Optimal antipseudomonal ꞵ-lactam drug dosing recommendations in critically-ill Asian patients receiving CRRT.
    Journal of critical care, 2022, Volume: 72

    Topics: Anti-Bacterial Agents; Body Weight; Cefepime; Ceftazidime; Critical Illness; Humans; Lactams; Meropenem; Microbial Sensitivity Tests; Piperacillin; Piperacillin, Tazobactam Drug Combination

2022
Population pharmacokinetics of piperacillin in febrile children receiving cancer chemotherapy: the impact of body weight and target on an optimal dosing regimen.
    The Journal of antimicrobial chemotherapy, 2019, 10-01, Volume: 74, Issue:10

    Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Body Weight; Child; Child, Preschool; Female; Fever; Glomerular Filtration Rate; Humans; Infant; Male; Microbial Sensitivity Tests; Neoplasms; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam

2019
Population Pharmacokinetics and Pharmacodynamics of Piperacillin/Tazobactam in Patients with Nosocomial Infections.
    European journal of drug metabolism and pharmacokinetics, 2016, Volume: 41, Issue:4

    Topics: Anti-Bacterial Agents; Body Weight; Cross Infection; Female; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam

2016
Piperacillin population pharmacokinetics in critically ill patients with multiple organ dysfunction syndrome receiving continuous venovenous haemodiafiltration: effect of type of dialysis membrane on dosing requirements.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Body Weight; Chromatography, Liquid; Critical Illness; Female; Hemodiafiltration; Humans; Infusions, Intravenous; Male; Mass Spectrometry; Microbial Sensitivity Tests; Middle Aged; Multiple Organ Failure; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasma; Prospective Studies; Tertiary Care Centers; Young Adult

2016
Optimising piperacillin/tazobactam dosing in paediatrics.
    International journal of antimicrobial agents, 2007, Volume: 30, Issue:4

    Topics: Age Factors; Anti-Bacterial Agents; Body Weight; Child; Child, Preschool; Computer Simulation; Demography; Drug Labeling; Humans; Infant; Metabolic Clearance Rate; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Regression Analysis; Tissue Distribution

2007
Protective effects of N-benzoyl amino acids on cisplatin nephrotoxicity in rats.
    Biological & pharmaceutical bulletin, 1996, Volume: 19, Issue:11

    Topics: Alanine; Animals; Antineoplastic Agents; Blood Urea Nitrogen; Body Weight; Cisplatin; Creatinine; Kidney; Liver; Male; Organ Size; Piperacillin; Rats; Rats, Wistar

1996
Reversible bone marrow depression by high-dose piperacillin/tazobactam.
    British journal of haematology, 1996, Volume: 95, Issue:4

    Topics: Adolescent; Body Weight; Bone Marrow Diseases; Drug Therapy, Combination; Female; Fever; Humans; Neutropenia; Pancytopenia; Penicillanic Acid; Piperacillin; Tazobactam; Weight Loss

1996